Citations to this article
Abstract
Adoptive T cell transfer (ACT) immunotherapy benefits from early differentiated stem cell memory T (Tscm) cells capable of persisting in the long term and generating potent antitumor effectors. Due to their paucity ex vivo, Tscm cells can be derived from naive precursors, but the molecular signals at the basis of Tscm cell generation are ill-defined. We found that less differentiated human circulating CD8+ T cells display substantial antioxidant capacity ex vivo compared with more differentiated central and effector memory T cells. Limiting ROS metabolism with antioxidants during naive T cell activation hindered terminal differentiation, while allowing expansion and generation of Tscm cells. N-acetylcysteine (NAC), the most effective molecule in this regard, induced transcriptional and metabolic programs characteristic of self-renewing memory T cells. Upon ACT, NAC-generated Tscm cells established long-term memory in vivo and exerted more potent antitumor immunity in a xenogeneic model when redirected with CD19-specific CAR, highlighting the translational relevance of NAC as a simple and inexpensive method to improve ACT.
Authors
Karolina Pilipow, Eloise Scamardella, Simone Puccio, Sanjivan Gautam, Federica De Paoli, Emilia M.C. Mazza, Gabriele De Simone, Sara Polletti, Marta Buccilli, Veronica Zanon, Pietro Di Lucia, Matteo Iannacone, Luca Gattinoni, Enrico Lugli
Total citations by year
Citation information
Citations to this article (72)
| Title and authors | Publication | Year |
|---|---|---|
|
Effects of functional antioxidants on the expansion of gamma delta T-cells and their cellular cytotoxicity against bladder cancer cells
Pan Y, Shih HJ, Chuang SH, Chang CP, Hsiao CH, Chiu YH, Wang PF, Lin CC, Shih PH |
BMC Cancer | 2025 |
|
Recent advances and challenges of cellular immunotherapies in lung cancer treatment.
Yang C, Liu Y, Huang Z, Liu S, Zhang X, Liu Q, Dai J |
Experimental hematology & oncology | 2025 |
|
Hemoglobin alpha regulates T-lymphocyte activation and mitochondrial function
Reed EC, Lauten TH, Natour T, Pitts LJ, Jojo CN, Griffin BL, Pasupuleti S, Case AJ |
bioRxiv | 2025 |
|
Dysfunctional mitochondria in ageing T cells: a perspective on mitochondrial quality control mechanisms.
Luo L, Lechuga-Vieco AV, Sattentau C, Borsa M, Simon AK |
EMBO reports | 2025 |
|
Sustaining antitumor response of CD8+ T cells by mediating cross-talk between A2AR and GSH/Gpx4 metabolic axes
Siqi Chen, Jie Fan, Ping Xie, Jihae Ahn, Michelle Fernandez, jennifer Wu, Derek A. Wainwright, Deyu Fang, Jeffrey Sosman, Yong Wan, Yi Zhang, Navdeep S. Chandel, Bin Zhang |
Journal of Clinical Investigation | 2024 |
|
Intracellular K+ Limits T-cell Exhaustion and Preserves Antitumor Function.
Collier C, Wucherer K, McWhorter M, Jenkins C, Bartlett A, Roychoudhuri R, Eil R |
Cancer immunology research | 2024 |
|
Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment
Krug A, Tosolini M, Madji Hounoum B, Fournié JJ, Geiger R, Pecoraro M, Emond P, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E |
Journal of experimental & clinical cancer research : CR | 2024 |
|
Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8(+) T cells.
Han C, Ge M, Xing P, Xia T, Zhang C, Ma K, Ma Y, Li S, Li W, Liu X, Zhang B, Zhang L, Zhang L |
Cell Death and Disease | 2024 |
|
Metabolic instruction of the graft-versus-leukemia immunity
Burk AC, Apostolova P |
Frontiers in immunology | 2024 |
|
Metabolic plasticity of T cell fate decision.
Pan X, Wang J, Zhang L, Li G, Huang B |
Chinese Medical Journal | 2024 |
|
Metabolic priming of GD2 TRAC-CAR T cells during manufacturing promotes memory phenotypes while enhancing persistence
Cappabianca D, Pham D, Forsberg MH, Bugel M, Tommasi A, Lauer A, Vidugiriene J, Hrdlicka B, McHale A, Sodji QH, Skala MC, Capitini CM, Saha K |
2024 | |
|
NR4A ablation improves mitochondrial fitness for long persistence in human CAR-T cells against solid tumors
Nakagawara K, Ando M, Srirat T, Mise-Omata S, Hayakawa T, Ito M, Fukunaga K, Yoshimura A |
Journal for Immunotherapy of Cancer | 2024 |
|
Immunometabolism of CD8+ T cell differentiation in cancer
Shi H, Chen S, Chi H |
Trends in cancer | 2024 |
|
Stem-like CD8+ T cells in cancer
Steiner C, Denlinger N, Huang X, Yang Y |
Frontiers in Immunology | 2024 |
|
NaCl enhances CD8(+) T cell effector functions in cancer immunotherapy.
Scirgolea C, Sottile R, De Luca M, Susana A, Carnevale S, Puccio S, Ferrari V, Lise V, Contarini G, Scarpa A, Scamardella E, Feno S, Camisaschi C, De Simone G, Basso G, Giuliano D, Mazza EMC, Gattinoni L, Roychoudhuri R, Voulaz E, Di Mitri D, Simonelli M, Losurdo A, Pozzi D, Tsui C, Kallies A, Timo S, Martano G, Barberis E, Manfredi M, Rescigno M, Jaillon S, Lugli E |
Nature immunology | 2024 |
|
Chemical Immunology: Recent Advances in Tool Development and Applications
Shi Y, Bashian EE, Hou Y, Wu P |
Cell chemical biology | 2024 |
|
Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy
Lu S, Wang C, Ma J, Wang Y |
Frontiers in Immunology | 2024 |
|
Acetylcysteine synergizes PD-1 blockers against colorectal cancer progression by promoting TCF1+PD1+CD8+ T cell differentiation
Zhou W, Qu M, Yue Y, Zhong Z, Nan K, Sun X, Wu Q, Zhang J, Chen W, Miao C |
Cell Communication and Signaling : CCS | 2024 |
|
A structural, genetic and clinical comparison of CAR-T cells and CAR-NK cells: companions or competitors?
Andrea AE, Chiron A, Sarrabayrouse G, Bessoles S, Hacein-Bey-Abina S |
Frontiers in Immunology | 2024 |
|
Reprogramming T-cell metabolism to enhance adoptive cell therapies.
Kates M, Saibil SD |
International immunology | 2024 |
|
Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells
Yang MQ, Zhang SL, Sun L, Huang LT, Yu J, Zhang JH, Tian Y, Han CB, Ma JT |
Molecular Cancer | 2024 |
|
Intercellular nanotube-mediated mitochondrial transfer enhances T-cell metabolic fitness and antitumor efficacy
Baldwin JG, Heuser-Loy C, Saha T, Schelker R, Slavkovic-Lukic D, Strieder N, Hernandez-Lopez I, Rana N, Barden M, Mastrogiovanni F, Martín-Santos A, Raimondi A, Brohawn P, Higgs BW, Gebhard C, Kapoor V, Telford WG, Gautam S, Xydia M, Beckhove P, Frischholz S, Schober K, Kontarakis Z, Corn JE, Iannacone M, Inverso D, Rehli M, Fioravanti J, Sengupta S, Gattinoni L |
Cell | 2024 |
|
Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
de Oliveira Canedo G, Roddie C, Amrolia PJ |
Blood Advances | 2024 |
|
Towards next-generation TIL therapy: TILs enriched in neoepitope-specific T cells.
Arnaud M, Coukos G, Harari A |
Clinical and Translational Medicine | 2023 |
|
IL-21, Inflammatory Cytokines and Hyperpolarized CD8+ T Cells Are Central Players in Lupus Immune Pathology
Sengupta S, Bhattacharya G, Mohanty S, Shaw SK, Jogdand GM, Jha R, Barik PK, Parida JR, Devadas S |
Antioxidants | 2023 |
|
T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
Chi X, Luo S, Ye P, Hwang WL, Cha JH, Yan X, Yang WH |
Frontiers in immunology | 2023 |
|
Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
He B, Mai Q, Pang Y, Deng S, He Y, Xue R, Xu N, Zhou H, Liu X, Xuan L, Li C, Liu Q |
Frontiers in immunology | 2023 |
|
Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy
Li W, Pan X, Chen L, Cui H, Mo S, Pan Y, Shen Y, Shi M, Wu J, Luo F, Liu J, Li N |
Frontiers in immunology | 2023 |
|
Recent advances in CD8+ T cell-based immune therapies for HIV cure
Arenas VR, Rugeles MT, Perdomo-Celis F, Taborda N |
Heliyon | 2023 |
|
T memory stem cell characteristics in autoimmune diseases and their promising therapeutic values
Fazeli P, Kalani M, Hosseini M |
Frontiers in immunology | 2023 |
|
Challenges and new technologies in adoptive cell therapy.
Zhang P, Zhang G, Wan X |
Journal of Hematology & Oncology | 2023 |
|
Immunometabolism: a new dimension in immunotherapy resistance.
Xiao C, Xiong W, Xu Y, Zou J, Zeng Y, Liu J, Peng Y, Hu C, Wu F |
Frontiers of Medicine | 2023 |
|
DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies
Giardino Torchia ML, Moody G |
Frontiers in immunology | 2023 |
|
CAR T-cell manufacturing from naive/stem memory T-lymphocytes enhances antitumor responses while curtailing cytokine release syndrome
Silvia Arcangeli, Camilla Bove, Claudia Mezzanotte, Barbara Camisa, Laura Falcone, Francesco Manfredi, Eugenia Bezzecchi, Rita El Khoury, Rossana Norata, Francesca Sanvito, Maurilio Ponzoni, Beatrice Greco, Marta A Moresco, Matteo G. Carrabba, Fabio Ciceri, Chiara Bonini, Attilio Bondanza, Monica Casucci |
Journal of Clinical Investigation | 2022 |
|
New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy
N Oberholtzer, K Quinn, P Chakraborty, S Mehrotra |
Cells | 2022 |
|
Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model
C Cai, Y Peng, E Shen, R Wan, L Gao, Y Gao, Y Zhou, Q Huang, Y Chen, P Liu, C Guo, Z Feng, X Zhang, Y Liu, H Shen, S Zeng, Y Han |
EBioMedicine | 2022 |
|
Phenotypic and Immunometabolic Aspects on Stem Cell Memory and Resident Memory CD8+ T Cells
La Manna MP, Shekarkar Azgomi M, Tamburini B, Badami GD, Mohammadnezhad L, Dieli F, Caccamo N |
Frontiers in immunology | 2022 |
|
Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies.
Xiao X, Wang Y, Zou Z, Yang Y, Wang X, Xin X, Tu S, Li Y |
Frontiers in immunology | 2022 |
|
Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells
Madison BB, Patil D, Richter M, Li X, Tong M, Cranert S, Wang X, Martin R, Xi H, Tan Y, Weiss L, Marquez K, Coronella J, Shedlock DJ, Ostertag EM |
2022 | |
|
NAC, NAC, Knockin’ on Heaven's door: Interpreting the mechanism of action of N-acetylcysteine in tumor and immune cells
Kalyanaraman B |
Redox Biology | 2022 |
|
Clinical implications of T cell exhaustion for cancer immunotherapy.
Chow A, Perica K, Klebanoff CA, Wolchok JD |
Nature reviews. Clinical oncology | 2022 |
|
Role of CAR T Cell Metabolism for Therapeutic Efficacy
Rial Saborido J, Völkl S, Aigner M, Mackensen A, Mougiakakos D |
Cancers | 2022 |
|
The role of CXCR3 and its ligands in cancer
Wang X, Zhang Y, Wang S, Ni H, Zhao P, Chen G, Xu B, Yuan L |
Frontiers in Oncology | 2022 |
|
Manipulating T-cell metabolism to enhance immunotherapy in solid tumor
Chen C, Wang Z, Ding Y, Qin Y |
Frontiers in immunology | 2022 |
|
Cancer therapy in mice using a pure population of CD8+ T cell specific to the AH1 tumor rejection antigen
M Stringhini, I Spadafora, M Catalano, J Mock, P Probst, R Spörri, D Neri |
Cancer Immunology, Immunotherapy | 2021 |
|
Metabolic barriers to cancer immunotherapy
K DePeaux, GM Delgoffe |
Nature Reviews Immunology | 2021 |
|
Improving CAR T-Cell Persistence
V Pietrobon, LA Todd, A Goswami, O Stefanson, Z Yang, F Marincola |
International journal of molecular sciences | 2021 |
|
T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies
V Janelle, JS Delisle |
Cancers | 2021 |
|
CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
P Thomas, N Galopin, E Bonérandi, B Clémenceau, S Fougeray, S Birklé |
Cancers | 2021 |
|
Enhancing adoptive CD8 T cell therapy by systemic delivery of tumor associated antigens
DE Jæhger, ML Hübbe, MK Kræmer, G Clergeaud, AV Olsen, C Stavnsbjerg, MN Wiinholt, A Kjær, JR Henriksen, AE Hansen, TL Andresen |
Scientific Reports | 2021 |
|
Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy
RD Leone, JD Powell |
Cancer immunology research | 2021 |
|
Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
NS Aboelella, C Brandle, T Kim, ZC Ding, G Zhou |
Cancers | 2021 |
|
Vitamin C, From Supplement to Treatment: A Re-Emerging Adjunct for Cancer Immunotherapy?
L Kouakanou, C Peters, CE Brown, D Kabelitz, LD Wang |
Frontiers in immunology | 2021 |
|
Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production
JB Lee, DH Khan, R Hurren, M Xu, Y Na, H Kang, S Mirali, X Wang, M Gronda, Y Jitkova, N MacLean, A Arruda, Z Alaniz, MY Konopleva, M Andreeff, MD Minden, L Zhang, AD Schimmer |
Blood | 2021 |
|
Arginine Deiminase Induces Immunogenic Cell Death and Is Enhanced by N-acetylcysteine in Murine MC38 Colorectal Cancer Cells and MDA-MB-231 Human Breast Cancer Cells In Vitro
Z Huang, H Hu |
Molecules (Basel, Switzerland) | 2021 |
|
HIV-Infected Individuals on ART With Impaired Immune Recovery Have Altered Plasma Metabolite Profiles
S Nyström, M Govender, SH Yap, A Kamarulzaman, R Rajasuriar, M Larsson |
Open Forum Infectious Diseases | 2021 |
|
Effect of antioxidants coenzyme Q10 and β‑carotene on the cytotoxicity of vemurafenib against human malignant melanoma
C Hu, Y Huang, P Luo, Y Yang |
Oncology Letters | 2021 |
|
Rejuvenating Effector/Exhausted CAR T Cells to Stem Cell Memory–Like CAR T Cells By Resting Them in the Presence of CXCL12 and the NOTCH Ligand
Ando M, Kondo T, Tomisato W, Ito M, Shichino S, Srirat T, Mise-Omata S, Nakagawara K, Yoshimura A |
2021 | |
|
IRF4 instructs effector Treg differentiation and immune suppression in human cancer
Giorgia Alvisi, Jolanda Brummelman, Simone Puccio, Emilia Maria Cristina Mazza, Elisa Paoluzzi Tomada, Agnese Losurdo, Veronica Zanon, Clelia Peano, Federico S. Colombo, Alice Scarpa, Marco Alloisio, Ajithkumar Vasanthakumar, Rahul Roychoudhuri, Marinos Kallikourdis, Massimiliano Pagani, Egesta Lopci, Pierluigi Novellis, Jonas Blume, Axel Kallies, Giulia Veronesi, Enrico Lugli |
Journal of Clinical Investigation | 2020 |
|
Glutathione Restricts Serine Metabolism to Preserve Regulatory T Cell Function
H Kurniawan, DG Franchina, L Guerra, L Bonetti, , M Grusdat, L Schlicker, O Hunewald, C Dostert, MP Merz, C Binsfeld, GS Duncan, S Farinelle, Y Nonnenmacher, J Haight, DD Gupta, A Ewen, R Taskesen, R Halder, Y Chen, C Jäger, M Ollert, P Wilmes, V Vasiliou, IS Harris, CB Knobbe-Thomsen, JD Turner, TW Mak, M Lohoff, J Meiser, K Hiller, D Brenner |
Cell Metabolism | 2020 |
|
Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
S Arcangeli, L Falcone, B Camisa, FD Girardi, M Biondi, F Giglio, F Ciceri, C Bonini, A Bondanza, M Casucci |
Frontiers in immunology | 2020 |
|
The S enantiomer of 2-hydroxyglutarate increases central memory CD8 populations and improves CAR-T therapy outcome
IP Foskolou, L Barbieri, A Vernet, D Bargiela, PP Cunha, P Velica, E Suh, S Pietsch, R Matuleviciute, H Rundqvist, D McIntyre, KG Smith, RS Johnson |
Blood Advances | 2020 |
|
Stem, Effector, and Hybrid States of Memory CD8+ T Cells
E Lugli, G Galletti, SK Boi, BA Youngblood |
Trends in Immunology | 2020 |
|
Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies
Y Nie, W Lu, D Chen, H Tu, Z Guo, X Zhou, M Li, S Tu, Y Li |
Biomarker Research | 2020 |
|
Metabolic Traits in Cutaneous Melanoma
M Neagu |
Frontiers in Oncology | 2020 |
|
Immunometabolism in haematopoietic stem cell transplantation and adoptive cellular therapies
EL Braverman, G Waltz, CA Byersdorfer |
Current Opinion in Hematology | 2020 |
|
IL4I1 Accelerates the Expansion of Effector CD8+ T Cells at the Expense of Memory Precursors by Increasing the Threshold of T-Cell Activation
ML Puiffe, A Dupont, N Sako, J Gatineau, JL Cohen, D Mestivier, A Lebon, A Prévost-Blondel, F Castellano, V Molinier-Frenkel |
Frontiers in immunology | 2020 |
|
Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies
Gurusamy D, Henning AN, Yamamoto TN, Yu Z, Zacharakis N, Krishna S, Kishton RJ, Vodnala SK, Eidizadeh A, Jia L, Kariya CM, Black MA, Eil R, Palmer DC, Pan JH, Sukumar M, Patel SJ, Restifo NP |
Cancer Cell | 2020 |
|
Cancer neoantigens targeted by adoptive T cell transfer: private no more
Enrico Lugli, Pia Kvistborg, Giovanni Galletti |
Journal of Clinical Investigation | 2019 |
|
CXCR3 Identifies Human Naive CD8 + T Cells with Enhanced Effector Differentiation Potential
GD Simone, EM Mazza, A Cassotta, AN Davydov, M Kuka, V Zanon, FD Paoli, E Scamardella, M Metsger, A Roberto, K Pilipow, FS Colombo, E Tenedini, E Tagliafico, L Gattinoni, D Mavilio, C Peano, DA Price, SP Singh, JM Farber, V Serra, F Cucca, F Ferrari, V Orrù, E Fiorillo, M Iannacone, DM Chudakov, F Sallusto, E Lugli |
Journal of immunology (Baltimore, Md. : 1950) | 2019 |
|
Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection
ZM Ndhlovu, SW Kazer, T Nkosi, F Ogunshola, DM Muema, G Anmole, SA Swann, A Moodley, K Dong, T Reddy, MA Brockman, AK Shalek, T Ndungu, BD Walker |
Science Translational Medicine | 2019 |
|
Defining ‘T cell exhaustion’
CU Blank, WN Haining, W Held, PG Hogan, A Kallies, E Lugli, RC Lynn, M Philip, A Rao, NP Restifo, A Schietinger, TN Schumacher, PL Schwartzberg, AH Sharpe, DE Speiser, EJ Wherry, BA Youngblood, D Zehn |
Nature Reviews Immunology | 2019 |
